tiprankstipranks
China Resources Pharmaceutical Group Ltd. (DE:640)
:640
Germany Market

China Resources Pharmaceutical Group Ltd. (640) Income Statement

Compare
0 Followers

China Resources Pharmaceutical Group Ltd. Income Statement

Last quarter (Q2 2024), China Resources Pharmaceutical Group Ltd.'s total revenue was HK$139.35B, an increase of 10.85% from the same quarter last year. In Q2, China Resources Pharmaceutical Group Ltd.'s net income was HK$2.82B. See China Resources Pharmaceutical Group Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
HK$ 270.40BHK$ 254.11BHK$ 236.81BHK$ 200.42BHK$ 204.45B
Gross Profit
HK$ 43.37BHK$ 39.13BHK$ 35.38BHK$ 32.29BHK$ 34.02B
Operating Expenses
HK$ 29.35BHK$ 28.32BHK$ 26.13BHK$ 23.82BHK$ 25.99B
Depreciation and Amortization
HK$ 3.16BHK$ 3.15BHK$ 2.82BHK$ 2.44BHK$ 2.36B
EBITDA
HK$ 15.43BHK$ 15.47BHK$ 11.95BHK$ 12.47BHK$ 12.58B
Operating Income
HK$ 12.15BHK$ 10.81BHK$ 9.25BHK$ 8.47BHK$ 8.02B
Other Income/Expenses
HK$ -2.27BHK$ -2.45BHK$ -2.38BHK$ -2.51BHK$ -3.80B
Pretax Income
HK$ 9.88BHK$ 9.47BHK$ 8.09BHK$ 6.87BHK$ 6.50B
Net Income
HK$ 3.85BHK$ 3.50BHK$ 3.08BHK$ 2.78BHK$ 3.29B
Per Share Metrics
HK$ ―HK$ ―HK$ ―HK$ ―HK$ ―
Basic EPS
HK$ 0.68HK$ 0.66HK$ 0.60HK$ 0.52HK$ 0.52
Diluted EPS
HK$ 0.68HK$ 0.66HK$ 0.60HK$ 0.52HK$ 0.52
Weighted Average Shares Outstanding
6.28B 6.28B 6.28B 6.28B 6.28B
Weighted Average Shares Outstanding (Diluted)
6.28B 6.28B 6.28B 6.28B 6.28B
Currency in HKD

China Resources Pharmaceutical Group Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis